NCT04703699 - Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis. | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

May 30, 2024

Study Completion Date

November 30, 2028

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

Myval Transcatheter Heart Valve Series

Myval™ THV is a newer-generation balloon-expandable THV characterized by a nickel-cobalt alloy frame composed of a single element - hexagon arranged in a hybrid honeycomb fashion.

Trial Locations (8)

4818

RECRUITING

Amphia Ziekenhui, Breda

20149

RECRUITING

Clinical Institute Saint Ambrogio, Milan

35010

RECRUITING

Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria

47003

RECRUITING

Hospital Cliinico Univertistario de Valladolid, Valladolid

Unknown

RECRUITING

North Estonia Medical center, Tallinn

RECRUITING

University Medical Centre Ljubljana, Ljubljana

RECRUITING

Kocaeli University School of Medicine, Kocaeli

80-309

RECRUITING

University of Gdansk, Gdansk